Rivaroxaban ACS Specialist Cohort Event Monitoring Study

NCT02673437 · clinicaltrials.gov ↗
COMPLETED
Status
701
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Drug Safety Research Unit, Southampton, UK